Quick Answer
Emmaus Life Sciences, Inc. reported Operating Income of $231.0 thousand for fiscal year 2025.
Emmaus Life Sciences, Inc. Operating Income — Annual History
| Fiscal Year | Operating Income | YoY Change |
|---|---|---|
| 2025 | $231.0K | +112.2% |
| 2024 | -$1.89M | -153.5% |
| 2023 | $3.54M | +153.8% |
| 2022 | -$6.59M | -7.5% |
| 2021 | -$6.13M | -19050.0% |
| 2020 | -$32.0K | +99.3% |
| 2019 | -$4.51M | +46.6% |
| 2018 | -$8.45M | +17.5% |
| 2018 | -$10.24M | -44.2% |
| 2017 | -$7.10M | -88.6% |
| 2016 | -$3.77M | -42.2% |
| 2015 | -$2.65M | +30.6% |
| 2014 | -$3.82M | +9.1% |
| 2013 | -$4.20M | +12.6% |
| 2012 | -$4.81M | +9.2% |
| 2011 | -$5.29M | — |
Quarterly Operating Income
| Quarter Ending | Operating Income | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $695.0K | -15.3% | +287.8% |
| June 30, 2025 | -$370.0K | -163.6% | +62.2% |
| March 31, 2025 | -$980.0K | +64.2% | -219.4% |
| September 30, 2024 | $821.0K | +3320.8% | +41.1% |
| June 30, 2024 | $582.0K | -82.5% | +121.2% |
| March 31, 2024 | -$2.74M | -135.2% | -11516.7% |
| September 30, 2023 | $24.0K | +103.6% | -99.3% |
| June 30, 2023 | $3.33M | +331.0% | +385.5% |
- Emmaus Life Sciences, Inc. showed an increase of +112.2% in Operating Income compared to the prior fiscal year.
- Over the 2011–2025 period, Emmaus Life Sciences, Inc.’s operating income has grown by 104.4% (from -$5.29 million to $231.0 thousand).
- The most recent figure is from Emmaus Life Sciences, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 31, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: